Articles From: Spectranetics' EXCITE ISR Data to Be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Late-Breaking Clinical Trial Session in Washington, D.C. to Speedway Motorsports, Inc. Schedules 2014 Third Quarter Earnings Conference Call


Spectrum Brands Holdings, Inc. (NYSE:SPB), a global consumer products company with market-leading brands, announced today that its wholly owned subsidiary Spectrum Brands, Inc. (“Spectrum Brands”) intends to offer $250 million aggregate principal amount of senior notes (the “Notes”) and enter into a new term loan facility in an aggregate principal amount of €150 million (the “New Term Loan Facility”). The Notes will be offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to non-U.S. buyers in accordance with Regulation S under the Securities Act.
Sign-up for Spectrum Brands Announces Intention to Offer Senior Notes and Enter Into a New Term Loan Facility investment picks
Spectrum Brands Holdings, Inc. (NYSE: SPB) announced today that its wholly owned subsidiary Spectrum Brands, Inc. (“Spectrum Brands”) will sell U.S. $250 million aggregate principal amount of 6.125% Senior Notes due 2024 (the “Notes”) at a price of 100.00% of the par value.
Sign-up for Spectrum Brands Announces Pricing of Senior Notes Offering investment picks
Spectrum Brands Holdings, Inc. (NYSE: SPB) announced that its Board of Directors today declared a quarterly dividend of $0.30 per share on the Company’s common stock.
Sign-up for Spectrum Brands Holdings Declares Quarterly Common Stock Dividend of $0.30 Per Share investment picks
Spectrum Brands Holdings, Inc. (NYSE: SPB), a global and diversified consumer products company with market-leading brands, today reported record performance for fiscal 2014 ended September 30, 2014 with results that met or exceeded financial targets.
Sign-up for Spectrum Brands Holdings Reports Record Fiscal 2014 Results investment picks
Spectrum Brands Holdings, Inc. (NYSE: SPB), a global and diversified consumer products company with market-leading brands, announced today the signing of a definitive agreement to acquire Procter & Gamble’s (NYSE: PG) European pet food business, consisting of the complementary IAMS® and Eukanuba® premium brands for dogs and cats.
Sign-up for Spectrum Brands Holdings to Acquire Procter & Gamble’s European Pet Food Business investment picks
Spectrum Brands Holdings, Inc. (NYSE: SPB), a diversified and global consumer products company with market-leading brands, announced today it will release its fiscal 2014 fourth quarter and full year financial results for the period ended September 30, 2014 before the markets open on Thursday, November 20.
Sign-up for Spectrum Brands Holdings to Report Fiscal 2014 Fourth Quarter and Full Year Financial Results and Hold Conference Call and Webcast on November 20 investment picks
Spectrum Brands Holdings, Inc. (NYSE: SPB), a global and diversified consumer products company with market-leading brands, announced today its Hardware and Home Improvement Group (HHI) has completed the acquisition of privately owned Tell Manufacturing, Inc., a leading U.S. manufacturer and distributor of commercial doors, locks and hardware with annual revenues of nearly $40 million.
Sign-up for Spectrum Brands Holdings’ Hardware and Home Improvement (HHI) Group Completes Acquisition of Tell Manufacturing, Leading U.S. Provider of Commercial Doors, Locks and Hardware investment picks
Spectrum Brands Holdings, Inc. (NYSE: SPB), a global and diversified consumer products company with market-leading brands, announced today its Hardware and Home Improvement Group (HHI) has signed a definitive agreement to acquire privately owned Tell Manufacturing, Inc., a leading U.S. manufacturer and distributor of commercial doors, locks and hardware with annual revenues of nearly $40 million.
Sign-up for Spectrum Brands Holdings’ Hardware and Home Improvement (HHI) Group Signs Definitive Agreement to Acquire Tell Manufacturing investment picks
2014/9/23
The Procter & Gamble Company (NYSE:PG) today announced that Spectrum Brands has agreed to buy IAMS ® and EUKANUBA ® brands in Europe for an undisclosed amount.
Sign-up for Spectrum Brands to Buy P&G’s Remaining Pet Care Business investment picks
Spectrum Pharmaceuticals (NasdaqGS: SPPI) , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.
Sign-up for Spectrum Pharmaceuticals Announces Issue of a New Patent for Beleodaq™ (belinostat) for Injection with Patent Term Adjustment till 2027 investment picks
2014/10/30
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced it will host a teleconference and webcast with management to discuss the third quarter 2014 financial results, provide an update on the Company's business, and discuss expectations for the future.
Sign-up for Spectrum Pharmaceuticals Announces Third Quarter 2014 Financial Results Teleconference and Webcast investment picks
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced key presentations of clinical and scientific data related to its products at the 56th Annual Meeting of the American Society of Hematology (ASH), being held in San Francisco, California, from December 6-9, 2014.
Sign-up for Spectrum Pharmaceuticals Highlights 11 Abstracts at the 56th Annual Meeting of the American Society of Hematology (ASH) in San Francisco, California, December 6-9, 2014 investment picks
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, and CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China, announce the signing of license agreements whereby CASI has been granted exclusive rights to two of Spectrum Pharmaceuticals’ commercial oncology drugs, Zevalin® (ibritumomab tiuxetan) Injection for intravenous use and Marqibo® (vinCRIStine sulfate LIPOSOME injection) for intravenous infusion, and a Phase 3 drug candidate, Captisol-Enabled™ Melphalan (CE melphalan), for development and commercialization in China, including Taiwan, Hong Kong
Sign-up for Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs investment picks
- Spectrum receives a 19.99% stake (pre-transaction) in CASI, a NASDAQ-listed, oncology-focused Company with expertise and focus on markets in China and a $1.5 million promissory note Indication and usage MARQIBO is a liposomal vinca alkaloid indicated for the treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies.
Sign-up for Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs investment picks
2014/11/6
Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today financial results for the three-month period ended September 30, 2014.
Sign-up for Spectrum Pharmaceuticals Reports Strong Product Sales for the Third Quarter 2014; Sales of $47.9 Million up 15.6% Over Last Year investment picks
2014/11/12
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Jefferies 2014 Global London Healthcare Conference in London.
Sign-up for Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2014 Global London Healthcare Conference on November 19th investment picks
DALLAS, Nov.
Sign-up for Speed Commerce Acquires E-Commerce Services Provider Fifth Gear investment picks
DALLAS, Nov.
Sign-up for Speed Commerce Reports Fiscal Second Quarter 2015 Results investment picks
2014/11/14
http://media.marketwire.com/attachments/201411/290916_Speedemissions.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159067&ProfileId=051205&sourceType=1 ATLANTA, GA --
Sign-up for Speedemissions, Inc. Announces Financial Results for Third Quarter 2014 investment picks
Speedway Motorsports, Inc. (SMI) (NYSE: TRK) today reported third quarter 2014 total revenues of $139.8 million, adjusted non-GAAP income from continuing operations of $11.5 million or $0.28 per diluted share, and GAAP net income of $15.0 million or $0.36 per diluted share.
Sign-up for Speedway Motorsports Reports Results for the Three and Nine Months Ended September 30, 2014 and Reaffirms Full Year 2014 Guidance investment picks
Speedway Motorsports, Inc. (SMI) (NYSE:TRK) on October 16, 2014 declared a quarterly cash dividend of 15 cents per share of common stock.
Sign-up for Speedway Motorsports, Inc. Declares Quarterly Cash Dividend of 15 Cents Per Share investment picks
Speedway Motorsports, Inc. (SMI) (NYSE:TRK) has selected Sporting Innovations, a Kansas City-based sports technology company, to redefine and enhance the fan experience across its enterprise, including eight motorsports venues around the United States, which host some of the world’s largest events including NASCAR, INDYCAR, and NHRA race weekends.
Sign-up for Speedway Motorsports, Inc. Driving Fan Experience Initiatives, Partners with Sporting Innovations investment picks
Speedway Motorsports, Inc. (NYSE: TRK), a leading marketer, promoter and sponsor of motorsports entertainment, will host its quarterly conference call on Wednesday, October 29, 2014 at 10:00 a.m. (ET). Marcus G.
Sign-up for Speedway Motorsports, Inc. Schedules 2014 Third Quarter Earnings Conference Call investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Spectranetics' EXCITE ISR Data to Be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Late-Breaking Clinical Trial Session in Washington, D.C. to Speedway Motorsports, Inc. Schedules 2014 Third Quarter Earnings Conference Call
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent